Vaginal Swabs Are the Specimens of Choice When Screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results From a Multicenter Evaluation of the APTIMA Assays for Both Infections
- 1 December 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 32 (12) , 725-728
- https://doi.org/10.1097/01.olq.0000190092.59482.96
Abstract
Vaginal swabs were recently U.S. Food and Drug Administration-cleared for detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) using Gen-Probe Incorporated’s APTIMA COMBO2 Assay (AC2). We assessed the APTIMA CT Assay (ACT) for CT, APTIMA GC Assay (AGC) for GC, and AC2 for both organisms using patient- and clinician-collected vaginal swabs. Women attending family planning, obstetrics and gynecology, or sexually transmitted disease (STD) clinics had first-catch urines (FCUs), patient-collected vaginal swabs, clinician-collected vaginal swabs, and endocervical swabs tested by ACT, AGC, and AC2. A second endocervical swab and FCU were tested using BD ProbeTec (Becton Dickinson) for CT and GC. We calculated sensitivity and specificity using vaginal swabs to detect CT and GC. Of 1464 subjects enrolled, 180 had CT and 78 GC. ACT sensitivities and specificities for patient-collected vaginal swabs were 98.3% and 96.5%, respectively; for clinician-collected vaginal swabs, 97.2% and 95.2%, respectively. AGC sensitivities and specificities for patient-collected vaginal swabs were 96.1% and 99.3%, respectively; for clinician-collected vaginal swabs, 96.2% and 99.3%, respectively. AC2 results were similar. If an FCU tested positive for CT or GC, >94% of matching vaginal swabs were positive. Positive endocervical swabs showed slightly less concordance (>90% and >88%, respectively). More infected patients were identified using vaginal swabs than FCUs. With AC2, 171 CT-infected patients were identified using FCUs and 196 using patient-collected vaginal swabs. This difference was more pronounced for CT than for GC. Vaginal swab specimens allowed sensitive and specific detection of CT and GC in the APTIMA assays. Vaginal swabs identified as many infected patients as endocervical swabs and more than FCUs, and may well be the specimen of choice for screening.Keywords
This publication has 17 references indexed in Scilit:
- Comparing First-Void Urine Specimens, Self-Collected Vaginal Swabs, and Endocervical Specimens To DetectChlamydia trachomatisandNeisseria gonorrhoeaeby a Nucleic Acid Amplification TestJournal of Clinical Microbiology, 2003
- Vaginal Swabs Are Appropriate Specimens for Diagnosis of Genital Tract Infection with Chlamydia trachomatisJournal of Clinical Microbiology, 2003
- Performance of the APTIMA Combo 2 Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Female Urine and Endocervical Swab SpecimensJournal of Clinical Microbiology, 2003
- NAATs to diagnose Chlamydia trachomatis genital infection: a promise still unfulfilledExpert Review of Molecular Diagnostics, 2001
- Is the Routine Pelvic Examination Needed With the Advent of Urine-Based Screening for Sexually Transmitted Diseases?Archives of Pediatrics & Adolescent Medicine, 1999
- The vaginal introitus: A novel site for Chlamydia trachomatis testing in womenAmerican Journal of Obstetrics and Gynecology, 1996
- Noninvasive Tests for Diagnosis of Chlamydia trachomatis Infection: Application of Ligase Chain Reaction to First-Catch Urine Specimens of WomenThe Journal of Infectious Diseases, 1995
- Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urineThe Lancet, 1995
- Diagnosis Of Chlamydia Trachomatis Urethral Infection In Symptomatic And Asymptomatic Men By Testing First-Void Urine In A Ligase Chain Reaction AssayThe Journal of Infectious Diseases, 1994
- Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assayJournal of Clinical Microbiology, 1993